Your browser doesn't support javascript.
loading
Early generation of a precursor CD8 T cell that can adapt to acute or chronic viral infection.
McManus, Daniel T; Valanparambil, Rajesh M; Medina, Christopher B; Hu, Yinghong; Scharer, Christopher D; Sobierajska, Ewelina; Chang, Daniel Y; Wieland, Andreas; Lee, Judong; Nasti, Tahseen H; Hashimoto, Masao; Ross, James L; Prokhnevska, Nataliya; Cardenas, Maria A; Gill, Amanda L; Clark, Elisa C; Abadie, Kathleen; Kueh, Hao Yuan; Kaye, Jonathan; Au-Yeung, Byron B; Kissick, Haydn T; Ahmed, Rafi.
Afiliação
  • McManus DT; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.
  • Valanparambil RM; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA.
  • Medina CB; These authors contributed equally.
  • Hu Y; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.
  • Scharer CD; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA.
  • Sobierajska E; These authors contributed equally.
  • Chang DY; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.
  • Wieland A; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA.
  • Lee J; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.
  • Nasti TH; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA.
  • Hashimoto M; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA.
  • Ross JL; Department of Urology, Emory University School of Medicine, Atlanta, GA, USA.
  • Prokhnevska N; Department of Pathology, Mass General Brigham, Harvard Medical School, Boston, MA, USA.
  • Cardenas MA; Department of Otolaryngology, The Ohio State University College of Medicine, Columbus, OH.
  • Gill AL; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.
  • Clark EC; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA.
  • Abadie K; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.
  • Kueh HY; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA.
  • Kaye J; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.
  • Au-Yeung BB; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA.
  • Kissick HT; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.
  • Ahmed R; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA.
Res Sq ; 2024 Feb 12.
Article em En | MEDLINE | ID: mdl-38410458
ABSTRACT
Virus specific PD-1+ TCF-1+ TOX+ stem-like CD8+ T cells are essential for maintaining T cell responses during chronic infection and are also critical for PD-1 directed immunotherapy. In this study we have used the mouse model of chronic LCMV infection to examine when these virus specific stem-like CD8+ T cells are generated during the course of chronic infection and what is the role of antigen in maintaining the stem-like program. We found that these stem-like CD8+ T cells are generated early (day 5) during chronic infection and that antigen is essential for maintaining their stem-like program. This early generation of stem-like CD8+ T cells suggested that the fate commitment to this cell population was agnostic to the eventual outcome of infection and the immune system prepares a priori for a potential chronic infection. Indeed, we found that an identical virus specific stem-cell like CD8+ T cell population was also generated during acute LCMV infection but these cells were lost once the virus was cleared. To determine the fate of these early PD-1+TCF-1+TOX+ stem-like CD8+ T cells that are generated during both acute and chronic LCMV infection we set up two reciprocal adoptive transfer experiments. In the first experiment we transferred day 5 stem-like CD8+ T cells from chronically infected into acutely infected mice and examined their differentiation after viral clearance. We found that these early stem-like CD8+ T cells downregulated canonical markers of the chronic stem-like CD8+ T cells and expressed markers (CD127 and CD62L) associated with central memory CD8+ T cells. In the second experiment, we transferred day 5 stem-like cells from acutely infected mice into chronically infected mice and found that these CD8+ T cells could function like resource cells after transfer into a chronic environment by generating effector CD8+ T cells in both lymphoid and non-lymphoid tissues while also maintaining the number of stem-like CD8+ T cells. These findings provide insight into the generation and maintenance of virus specific stem-like CD8+ T cells that play a critical role in chronic viral infection. In particular, our study highlights the early generation of stem-like CD8+ T cells and their ability to adapt to either an acute or chronic infection. These findings are of broad significance since these novel stem-like CD8+ T cells play an important role in not only viral infections but also in cancer and autoimmunity.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article